David Sommerhalder
David Sommerhalder publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Cancer Immunotherapy and Biomarkers.
- World rank
- #1,384,481 of 7,710,434 ranked researchers
- Rank in United States
- #437,729 of 1,627,098
- Works
- 129
- Citations
- 669
- Citations per work
- 5.2
What does David Sommerhalder research?
David Sommerhalder's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6450.0%
- Medicine6450.0%
- Life Sciences4031.1%
- Everything else2418.9%
- 1Oncology30% of their works
- 2Molecular Biology20% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Pulmonary and Respiratory Medicine10% of their works
- 5Immunology7% of their works
- 6Cancer Research5% of their works
Research topics
Which keywords describe David Sommerhalder's research?
The keywords of their largest research topics: Breast Cancer, Tumor Microenvironment, Fc Receptors, Therapeutic Antibodies, Cancer Therapy, HER2, Trastuzumab and CDK4/6 Inhibitors.
- Fibroblast Activation Protein
- BRCA Mutation
- Chimeric Antigen Receptor
- CAR T Cells
- PD-1 and PD-L1
- CDK4/6 Inhibitors
- HER2
- Therapeutic Antibodies
- Tumor Microenvironment
- Breast Cancer
- Fc Receptors
- Cancer Therapy
- Trastuzumab
- Immune Checkpoint Blockade
- Palbociclib
- Cancer Genomics
- Mutational Signatures
- PARP Inhibitors
- Immunosuppression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Breast Cancer312 topics
- Tumor Microenvironment232 topics
- Fc Receptors221 topic
- Therapeutic Antibodies221 topic
- Cancer Therapy192 topics
- HER2171 topic
- Trastuzumab171 topic
- CDK4/6 Inhibitors141 topic
- Immune Checkpoint Blockade141 topic
- PD-1 and PD-L1141 topic
- Palbociclib141 topic
- CAR T Cells121 topic
- Cancer Genomics121 topic
- Chimeric Antigen Receptor121 topic
- Mutational Signatures121 topic
- BRCA Mutation101 topic
- PARP Inhibitors101 topic
- Fibroblast Activation Protein91 topic
- Immunosuppression91 topic
Where does David Sommerhalder work?
David Sommerhalder's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does David Sommerhalder have?
OpenAlex counts 129 works and 669 citations for David Sommerhalder, an h-index of 12, ranking #1,384,481 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Sommerhalder. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.